RxDoctor Payments DataLook up a doctor →

Brandi Ligon, APRN

Gerontology · Winter Park, FLNPI 1750846077

Payments from drug & device makers

$26,826in general payments, 2019–2025

Across 397 payments — averaging $67.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sobi, Inc$4K
  • AstraZeneca$2K
  • Johnson & Johnson$2K
  • Incyte Corporation$2K
  • Catalyst Pharmaceuticals, Inc.$1K
  • Daiichi Sankyo Inc.$924
  • plus $15K from 54 others

What the payments were for

  • Consulting fees$4001%
  • Speaking & faculty fees$2,3509%
  • Travel & lodging$1,1684%
  • Food & beverage$21,91582%
  • Education$9934%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sobi, Inc24$3,557
AstraZeneca(2 entities)36$2,287
Johnson & Johnson(2 entities)35$1,794
Incyte Corporation18$1,660
Catalyst Pharmaceuticals, Inc.3$1,250
Daiichi Sankyo Inc.16$924
Seagen Inc.18$922
Gilead(2 entities)13$838
GSK9$778
Novocure Inc.8$773
E.r. Squibb & Sons, L.L.C.6$694
Takeda Pharmaceuticals U.S.A., Inc.8$658
Sanofi10$539
Genentech USA, Inc.11$536
Servier Pharmaceuticals LLC7$525
Adaptive Biotechnologies Corporation2$491
Merck9$489
Amgen13$482
EMD Serono, Inc.5$482
Novartis22$471
Bristol Myers Squibb8$434
Bayer7$432
AbbVie7$427
Puma Biotechnology, Inc.6$365
Eisai Inc.8$359
Pfizer8$348
Astellas Pharma US Inc7$336
Lilly USA, LLC7$293
Jazz Pharmaceuticals Inc.3$256
Mirati Therapeutics, Inc.2$239
Stemline Therapeutics Inc.2$237
Novo Nordisk2$236
Apellis Pharmaceuticals, Inc.2$221
AMAG Pharmaceuticals, Inc.4$177
Taiho Oncology, Inc.4$167
Exelixis Inc.2$158
Karyopharm Therapeutics Inc.3$158
Pharmacosmos Therapeutics Inc.2$149
Geron Corporation3$138
Coherus Oncology, Inc.2$133
GE HealthCare1$130
Beone Medicines USA, Inc.1$130
Epizyme, Inc.1$122
Blueprint Medicines Corporation1$122
Deciphera Pharmaceuticals Inc.2$119
Pharmacyclics LLC, An Abbvie Company1$116
G1 Therapeutics, Inc.2$96
Boehringer Ingelheim4$84
Sanofi-aventis U.S. LLC1$78
Morphosys, US Inc.4$74
Acrotech Biopharma Inc.2$49
Octapharma USA, Inc.1$44
Regeneron Healthcare Solutions, Inc.2$43
Dova Pharmaceuticals2$41
CSL Behring2$41
Array Biopharma Inc3$41
Global Blood Therapeutics, Inc.2$29
Clovis Oncology, Inc.1$22
Verity Pharmaceuticals Inc.1$16
Foundation Medicine, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,826 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida →

Medicare billing

Part B allowed, 2024
$53,152
Medicare patients
291
Services billed
809

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Winter Park

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →